Search

As genomic testing becomes more routine for cellpath labs, there is an increased need for
assessment of the tumour content for the more complex tests in particular, in order to ensure
there is enough tumour material to ensure the test result is valid.

Tumour tissue however is mixed, usually containing both tumour and non-tumour cells. Tumours
are also heterogenous, with some areas more relevant for a given test than others. For this
reason, the region of tumour that the DNA/ RNA is extracted from must be assessed to ensure it is
suitable and contains a sufficient amount of tumour cells for genomic analysis.

This course has been developed for histopathologists, clinical scientists and biomedical scientists
involved in the selection of tumour samples for genomic testing.

Summary of branch activities since the last AGM.
Featured talks from Sarah May, IBMS deputy chief executive- Advancing in all fronts: advanced clinical practice - the practicalities and politics.
Linda Bowes, Manchester Metropolitan University MSc poster prize winner- An assessment of the utility of CD15, CD16 and CD56 in evaluating dysplasia severity in myelodysplastic syndromes.
Interactive CPD activities

Investigating the Dead: Human Remains from the Battle of Towton, AD1461, and what they can tell us’ by Tim Sutherland, battlefield archaeologist.

The 80th annual general meeting of the Institute of Biomedical Science will be held for members at 12 Coldbath Square, London EC1R 5HL and virtually via Zoom.

Join this special event organised by the IBMS London Branch Region and free to attend for all London region members.

To celebrate Biomedical Science Day, IBMS Support Hub is bringing you some fabulous 15 minute talks on ‘Specialisms in Biomedical Science’. Whether you are a Support Hub regular or new to the format - come along, ask questions & join the conversation!

The 1st annual Cell Therapy at the Limits conference is a two-day medical education meeting which brings together a notable faculty of globally acknowledged experts who will consider new scientific discoveries and therapies at the limits of cell therapy research and treatment.
The Chairs for the inaugural Cell Therapy event join us from some of the world’s leading research and clinical centres. With unique viewpoints from Europe and the US, they each bring different perspectives and experiences to the event, and they have jointly developed a programme which has broad appeal to clinical oncologists as well as a depth of experience from the speakers who are confirmed to attend.

Lectures on general Clinical Microbiology and Virology topics.

Haematology and Trauma Group Webinar
Trauma and Coagulopathy

One of the biggest challenges we face in the current era of personalized medicine, is to be able provide state of the art patient care on small biopsy specimens with limited cellularity.

The tutorial faculty will discuss salient morphology, pitfalls, and incorporation of ancillary studies and lay out an algorithmic approach to diagnosis with the judicious use of immunohistochemical panels and biomarker testing for prognostication and management.